GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference
09 Novembro 2023 - 9:00AM
Business Wire
GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout
Semerjian, Chief Executive Officer, will participate in a fireside
chat at the Jefferies London Healthcare Conference in London, UK on
Thursday, November 16, 2023 at 1:30 p.m. GMT/8:30 a.m. ET.
A live webcast of the fireside chat will be available on the
GlycoMimetics website at
https://ir.glycomimetics.com/investor-relations. An archived
recording will be available for 30 days following the event.
About GlycoMimetics, Inc.
GlycoMimetics is a late clinical-stage biotechnology company
discovering and developing glycobiology-based therapies for
cancers, including AML, and for inflammatory diseases. The
company’s science is based on an understanding of the role that
carbohydrates play in cell recognition. Its specialized chemistry
platform is being deployed to discover small molecule drugs--known
as glycomimetics--that alter carbohydrate-mediated recognition in
diverse disease states, including cancers and inflammation. As a
leader in this science, GlycoMimetics leverages this unique
approach to advance its pipeline of wholly-owned drug candidates.
The company’s goal is to develop transformative therapies for
diseases with high unmet medical need. GlycoMimetics is
headquartered in Rockville, MD in the BioHealth Capital Region.
Learn more at www.glycomimetics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231109940316/en/
Investors: Argot Partners Leo Vartorella 212-600-1902
Glycomimetics@argotpartners.com
GlycoMimetics (NASDAQ:GLYC)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
GlycoMimetics (NASDAQ:GLYC)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024